Self-assembled drug delivery systems. Part 5: Self-assemblies of a bolaamphiphilic prodrug containing dual zidovudine

International Journal of Pharmaceutics

Volumn 386, Issue 1-2, 2010, Pages 268-274

  Jin, Yiguang ^a   Qi, Ningning ^a,b   Tong, Li ^c   Chen, Dawei ^b  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^c BEIJING NORMAL UNIVERSITY   (China)

Author keywords

Anti HIV; Bolaamphiphilic; Macrophage; Molecular self assembly; Nanotechnology; Prodrug; Zidovudine

Indexed keywords

AMPHOPHILE; BOLAAMPHOPHILE; HYDROXYPROPYLMETHYLCELLULOSE; METHANOL; PENTADECANEDIOYL DIZIDOVUDINE; POLYSORBATE 20; UNCLASSIFIED DRUG; WATER; ZIDOVUDINE; ZIDOVUDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG STABILITY; DRUG STRUCTURE; HUMAN; HUMAN CELL; HYDROPHOBICITY; LIVER; MACROPHAGE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RABBIT; SPLEEN; TESTIS; TISSUE DISTRIBUTION;

ABSORPTION; ANIMALS; ANTI-HIV AGENTS; CELL LINE; CHEMISTRY, PHARMACEUTICAL; CYTOPATHOGENIC EFFECT, VIRAL; DOGS; DRUG CARRIERS; DRUG STABILITY; HIV-1; HUMANS; HYDROPHOBICITY; INJECTIONS, INTRAVENOUS; LIPIDS; METHANOL; METHYLCELLULOSE; MICELLES; NANOPARTICLES; POLYSORBATES; PRODRUGS; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; SOLVENTS; SURFACE-ACTIVE AGENTS; TECHNOLOGY, PHARMACEUTICAL; TISSUE DISTRIBUTION; ZIDOVUDINE;

EID: 74149085434     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.11.018     Document Type: Article

References (41)

1. Advanced Chemistry Development Inc., 2006. ACD/ChemSketch, Freeware Version 10.00. www.acdlabs.com, Toronto, ON, Canada.
2. Ambrosi M., Fratini E., Alfredsson V., Ninham B.W., Giorgi R., Nostro P.L., and Baglioni P. Nanotubes from a vitamin C-based bolaamphiphile. J. Am. Chem. Soc. 128 (2006) 7209-7214
3. Aquaro S., Caliò R., Balzarini J., Bellocchi M.C., Garaci E., and Perno C.F. Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir. Antiviral Res. 55 (2002) 209-225
4. Cappellacci L., Franchetti P., Vita P., Petrelli R., and Grifantini M. Synthesis and antitumor activity of a heterodinucleotide of BVDU and gemcitabine. Nucleosides Nucleotides Nucleic Acids (2008) 460-468
5. Cook J.L., Hunter C.A., Low C.M.R., Perez-Velasco A., and Vinter J.G. Solvent effects on hydrogen bonding. Angew. Chem. Int. Ed. 46 (2007) 3706-3709
6. Fabio K., Gaucheron J., Giorgio C.D., and Vierling P. Novel galactosylated polyamine bolaamphiphiles for gene delivery. Bioconjugate Chem. 14 (2003) 358-367
7. Fuhrhop J.-H., and Wang T. Bolaamphiphiles. Chem. Rev. 104 (2004) 2901-2937
8. Furtado M.R., Callaway D.S., Phair J.P., Kunstman K.J., Stanton J.L., Macken C.A., Perelson A.S., and Wolinsky S.M. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy. New Eng. J. Med. 340 (1999) 1614-1622
9. Gao P., and Liu M. Compression induced helical nanotubes in a spreading film of a bolaamphiphile at the air/water interface. Langmuir 22 (2006) 6727-6729
10. Garg M., Asthana A., Agashe H.B., Agrawal G.P., and Jain N.K. Stavudine-loaded mannosylated liposomes: in vitro anti-HIV-I activity, tissue distribution and pharmacokinetics. J. Pharm. Pharmacol. 58 (2006) 605-616
11. Guenther S., and Nair V. Binding modes of two novel dinucleotide inhibitors of HIV-1 integrase. Bioorg. Med. Chem. Lett. 12 (2002) 2233-2236
12. Heurtault B., Saulnier P., Pech B., Proust J.-E., and Benoit J.-P. Physico-chemical stability of colloidal lipid particles. Biomaterials 24 (2003) 4283-4300
13. Iwaura R., Yoshida K., Masuda M., Ohnishi-Kameyama M., Yoshida M., and Shimizu T. Oligonucleotide-templated self-assembly of nucleotide bolaamphiphiles: DNA-like nanofibers edged by a double-helical arrangement of A-T base pairs. Angew. Chem. Int. Ed. 42 (2003) 1009-1012
14. Iwaura R., Yoshida K., Masuda M., Yase K., and Shimizu T. Spontaneous fiber formation and hydrogelation of nucleotide bolaamphiphiles. Chem. Mater. 14 (2002) 3047-3053
15. Jin Y., Qiao Y., Li M., Ai P., and Hou X. Langmuir monolayers of the long-chain alkyl derivatives of a nucleoside analogue and the formation of self-assembled nanoparticles. Colloids Surf. B: Biointerfaces 42 (2005) 45-51
16. Jin Y., Tong L., Ai P., Li M., and Hou X. Self-assembled drug delivery systems. 1. Properties and in vitro/in vivo behavior of acyclovir self-assembled nanoparticles (SAN). Int. J. Pharm. 309 (2006) 199-207
17. Jin Y. Nanotechnology in pharmaceutical manufacturing. In: Gad S.C. (Ed). Pharmaceutical Manufacturing Handbook: Production and Processes (2008), John Wiley & Sons, Inc., Hoboken, New Jersey 1249-1288
18. Jin Y., Ai P., Xin R., and Chen D. Morphological transformation of self-assembled nanostructures prepared from cholesteryl acyl didanosine and the optimal formulation of nanoparticulate systems: effects of solvents, acyl chain length and poloxamer 188. J. Colloid Interface Sci. 326 (2008) 275-282
19. Jin Y., Chen S., Xin R., and Zhou Y. Monolayers of the lipid derivatives of isoniazid at the air/water interface and the formation of self-assembled nanostructures in water. Colloids Surf. B: Biointerfaces 64 (2008) 229-235
20. Jin Y., Xin R., Ai P., and Chen D. Self-assembled drug delivery systems. 2. Cholesteryl derivatives of antiviral nucleoside analogues: synthesis, properties and the vesicle formation. Int. J. Pharm. 350 (2008) 330-337
21. Jin Y., Ai P., Xin R., Tian Y., Dong J., Chen D., and Wang W. Self-assembled drug delivery systems. Part 3. In vitro/in vivo studies of the self-assembled nanoparticulates of cholesteryl acyl didanosine. Int. J. Pharm. 368 (2009) 207-214
22. Jin Y., Xing L., Tian Y., Li M., Gao C., Du L., Dong J., and Chen H. Self-assembled drug delivery systems. Part 4. In vitro/in vivo studies of the self-assemblies of cholesteryl-phosphonyl zidovudine. Int. J. Pharm. 345 (2009) 40-48
23. Kim J.-M., and Thompson D.H. Tetraether bolaform amphiphiles as models of archaebacterial membrane lipids: synthesis, differential scanning calorimetry, and monolayer studies. Langmuir 8 (1992) 631-644
24. Krielgaard L., Jones L.S., Randolph T.W., Frokjaer S., Flink J.M., Manning M.C., and Carpenter J.F. Effect of tween 20 on freeze-thawing- and agitation-induced aggregation of recombinant human factor XIII. J. Pharm. Sci. 87 (1998) 1593-1603
25. Lasch J. Interaction of detergents with lipid vesicles. Biochim. Biophys. Acta 1241 (1995) 269-292
26. Lau W.M., White A.W., Gallagher S.J., Donaldson M., McNaughton G., and Heard C.M. Scope and limitations of the co-drug approach to topical drug delivery. Curr. Pharm. Des. 14 (2008) 794-802
27. Lazrek H.B., Vasseur J.J., Secrist' III J., and Engels J.W. A glutaric acid ester as carrier system for sustained delivery of lamuvidine (3TC) dimers. Nucleosides Nucleotides Nucleic Acids 26 (2007) 1103-1106
28. Li S., Zheng F., Zhang X., and Wang W. Stability and rupture of archaebacterial cell membrane: a model study. J. Phys. Chem. B 113 (2009) 1143-1152
29. Meister A., and Blume A. Self-assembly of bipolar amphiphiles. Curr. Opin. Colloid Interface Sci. 12 (2007) 138-147
30. Muzzalupo R., Trombino S., Iemma F., Puoci F., Mesa C.L., and Picci N. Preparation and characterization of bolaform surfactant vesicles. Colloids Surf. B: Biointerfaces 46 (2005) 78-83
31. Romeo S., Parapini S., Dell'Agli M., Vaiana N., Magrone P., Galli G., Sparatore A., Taramelli D., and Bosisio E. Atovaquone-statine "double-drugs" with high antiplasmodial activity. ChemMedChem 3 (2008) 418-420
32. Roulet V., Satie A.-P., Ruffault A., Tortorec A.L., Denis H., Guist'hau O., Patard J.-J., Rioux-Leclerq N., Gicquel J., Jégou B., and Dejucq-Rainsford N. Susceptibility of human testis to human immunodeficiency virus-1 infection in situ and in vitro. Am. J. Pathol. 169 (2006) 2094-2103
33. Rubalcava C.G.d., Rodriguez J.L., Duro R., Alvarez-Lorenzo C., Concheiro A., and Seijo B. Interactions between liposomes and hydroxypropylmethylcellulose. Int. J. Pharm. 203 (2000) 99-108
34. Savelli G., Spreti N., and Profio P.D. Enzyme activity and stability control by amphiphilic self-organizing systems in aqueous solutions. Curr. Opin. Colloid Interface Sci. 5 (2000) 111-117
35. Shimizu T., Masuda M., and Minamikawa H. Supramolecular nanotube architectures based on amphiphilic molecules. Chem. Rev. 105 (2005) 1401-1443
36. Sirieix J., Viguerie N.L.-d., Riviere M., and Lattes A. Aggregation behavior of urocanic acid bolaamphiphiles. Langmuir 16 (2000) 9221-9224
37. Torchilin V.P. Nanoparticulates as Drug Carriers (2006), Imperial College Press, London
38. Wang L., Wang K., Santra S., Zhao X., Hilliard L.R., Smith J.E., Wu Y., and Tan W. Watching silica nanoparticles glow in the biological world. Anal. Chem. 78 (2006) 646-654
39. Weissig V., and Torchilin V.P. Cationic bolasomes with delocalized charge centers as mitochondria-specific DNA delivery systems. Adv. Drug Deliv. Rev. 49 (2001) 127-149
40. Yan Y., Xiong W., Li X., Lu T., Huang J., Li Z., and Fu H. Molecular packing parameter in bolaamphiphile solutions: adjustment of aggregate morphology by modifying the solution conditions. J. Phys. Chem. B 111 (2007) 2225-2230
41. Zhang H., Dornadula G., Beumont M., Livornese L., Uitert B.V., Henning K., and Pomerantz R.J. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. New Eng. J. Med. 339 (1998) 1803-1809